a three-fold increase in the risk of blood clots for drospirenone-containing products
San Diego, CA (PRWEB) September 11, 2012
The media spotlight is often a double-edged sword. No one knows this better than Lauren Steiner. And yet, gossip and rumor-mongering aside, the real story here is being overlooked according to Sean Burke of AttorneyOne.
According to court documents, on June 25th, 2012, California resident Lauren Steiner filed a lawsuit in California Eastern District Court (case no. 2:2012cv01688) alleging Yaz caused her to suffer from kidney stones. Yasmin, which was approved by the FDA in 2001, and its sister drug Yaz, which was approved in 2006, are oral contraceptives that combine estrogen and a fourth generation progestin, drospirenone, to prevent pregnancy. The drugs, manufactured by Bayer Healthcare Pharmaceuticals, are also used to treat premenstrual dysphoric disorder (PMDD) and certain types of moderate acne in women. Plaintiff claims that after taking Yaz she experienced severe pain and seeks compensatory and punitive damages.
As BusinessWeek reported on July 31st, 2012, Bayer said settlements of U.S. lawsuits over claims that its Yasmin line of birth-control pills caused blood clots in women have increased to more than $402 million. In a stockholders’ newsletter Bayer said that it has resolved almost 1,900 cases in which its Yasmin and Yaz contraceptives allegedly caused clots that can lead to heart attacks and strokes.
AttorneyOne.com, a recognized authority on law, can provide helpful advice and simple solutions including how to get in contact with legal counsel so that, in case of severe adverse events from Yasmin/Yaz, someone can easily and inexpensively deal with it. As Mr. Burke, director of Media Relations for AttorneyOne.com, added, “What all this information really illustrates is that threat from Yasmin/Yaz remains. For that reason, our focus should squarely fall on getting the word out and assisting people in finding the right legal assistance.”
On April 10, 2012, FDA updated the drug labels for drospirenone-containing birth control pills, including Yasmin and Yaz. The new labels report that some epidemiologic studies reported as high as a three-fold increase in the risk of blood clots for drospirenone-containing products when compared to products containing levonorgestrel or some other progestins.
AttorneyOne.com has further information on Yasmin lawsuits including how to get in contact with legal counsel.
Headquartered in San Diego, CA Attorney One was founded in 2004 and is not a law firm. They offer a nationwide legal service which helps consumers find the best representation for their legal needs. You can learn more about Attorney One at our website http://www.attorneyone.com. You can also find us on Facebook at http://www.facebook.com/AttorneyOne. Checkout earlier news from us at http://www.prweb.com/releases/2012/9/prweb9856315.htm.